Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit (original) (raw)
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy
Paul Essers
Radiotherapy and Oncology, 2020
View PDFchevron_right
HPV Prevalence and Prognostic Value in a Prospective Cohort of 255 Patients with Locally Advanced HNSCC: A Single-Centre Experience
Denis Soulières
International journal of otolaryngology, 2013
View PDFchevron_right
Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
Jad Hosri
ecancermedicalscience
View PDFchevron_right
Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients
yasemin karaca
Journal of cancer research and clinical oncology, 2016
View PDFchevron_right
HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients
Matthew Witek
Otorhinolaryngology-Head and Neck Surgery, 2017
View PDFchevron_right
Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC
Steffen Löck
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2018
View PDFchevron_right
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Andrew Dumit
Nature Cancer
View PDFchevron_right
Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation
Sebastian Sanduleanu
Frontiers in Oncology
View PDFchevron_right
Data from Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
Martin Jütz
2023
View PDFchevron_right
The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate‐risk HPV‐negative HNSCC
Igea Troiani
Cancer Medicine, 2021
View PDFchevron_right
Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit
sambit nanda
ecancermedicalscience
View PDFchevron_right
Extranodal extension is a strong prognosticator in HPV‐positive oropharyngeal squamous cell carcinoma
Jose Zevallos
The Laryngoscope, 2019
View PDFchevron_right
Prognostic Indicators in Head and Neck Oncology Including the New 7th Edition of the AJCC Staging System
Margaret Brandwein-Gensler
Head and Neck Pathology, 2010
View PDFchevron_right
HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors
Alfons Balm
Radiotherapy and Oncology, 2010
View PDFchevron_right
Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas
Christophe Depuydt
Oncology Reports, 2013
View PDFchevron_right
Head and neck cancer: improving outcomes with a multidisciplinary approach
Marco Merlano
Cancer Management and Research
View PDFchevron_right
A Prospective Randomised Trial Comparing Neoadjuvant Chemotherapy Followed by Concomitant Chemoradiation versus Concomitant Chemoradiation Alone in Locally Advanced Inoperable Head and Neck Squamous Cell Carcinoma
International Journal of Research & Review (IJRR)
https://www.ijrrjournal.com/IJRR\_Vol.6\_Issue.11\_Nov2019/Abstract\_IJRR0058.html, 2019
View PDFchevron_right
Novel Insights into Head and Neck Cancer using Next-Generation "Omic" Technologies
Fei-fei Liu
Cancer Research, 2015
View PDFchevron_right
Current trends in the etiology and diagnosis of HPV-related head and neck cancers
Mukesh Verma
Cancer Medicine, 2015
View PDFchevron_right
Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options
Paolo Bossi
Annals of Oncology, 2008
View PDFchevron_right
Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303
Barbara Burtness
Clinical Cancer Research, 2014
View PDFchevron_right
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
J.-p. Pignon
British Journal of Oral and Maxillofacial Surgery, 2009
View PDFchevron_right
Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
MYUNG-WHUN SUNG
The Korean Journal of Internal Medicine, 2018
View PDFchevron_right
The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial
Lena Specht
Radiotherapy and Oncology, 2011
View PDFchevron_right
Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases
Christine Podesta
Clinical Otolaryngology, 2019
View PDFchevron_right
Validation of the 8th edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy
Thomas Eade
BMC Cancer
View PDFchevron_right
Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition
Jacqueline Kelly
Oral Oncology, 2019
View PDFchevron_right
Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
Sigui Li
JNCI Journal of the National Cancer Institute, 2008
View PDFchevron_right
Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base
Jagar Jasem
Oral Oncology, 2016
View PDFchevron_right
Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone
Lawrence Yen, Skye Cheng
Head & Neck, 2009
View PDFchevron_right
Assay-based response evaluation in head and neck oncology: requirements for better decision making
Gunnar Wichmann
European Archives of Oto-Rhino-Laryngology, 2010
View PDFchevron_right